RS

Rekha Singh

Active Director Director DIN 08480999
DIN 08480999 First appointment Jun 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2019
Shareholding value •••• Premium profile

About Rekha Singh

Data last updated:

Rekha Singh is a Director at Lifespell Pharma Private Limited (since 2019). The company operates in Healthcare. Lifespell Pharma Private Limited reported revenue of ₹21,496 (FY 2021).

DIN 08480999
Primary Designation Director
Industry Healthcare
First Appointment 13 Jun 2019
Oldest Company Age 7 yrs
Largest company Lifespell Pharma Private Limited · ₹21,496 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lifespell Pharma Private Limited U85100UP2019PTC118005
Director13 Jun 20192019₹21,496 (FY 2021)Active

Board colleagues of Rekha Singh

Directorship timeline

Open interactive timeline →
Lifespell Pharma Private Limited
Premium access

Shareholding and investment profile for Rekha Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rekha Singh

Rekha Singh currently holds 1 directorship: Lifespell Pharma Private Limited (Director, since 13 Jun 2019, revenue ₹21,496 (FY 2021)).

Rekha Singh was first appointed on 13 Jun 2019 as Director at Lifespell Pharma Private Limited.

The current boards of Rekha Singh's companies include Amit Kumar Singh (Lifespell Pharma Private Limited), Rakesh Kumar Singh (Lifespell Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available